UniQure N.V. (NASDAQ: QURE) and Apic Bio entered into a global licensing agreement for APB-102 to treat superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS).
Shares of Invitae Corp (NYSE: NVTA) came under pressure on Monday, after gaining more than 24% in January.
Despite having a restricting plan in place, the biotech company has a “long path to profitability,” according to Goldman Sachs.
One of the biggest struggles the cannabis industry still faces is the lack of financial services. Under existing federal law, financial institutions are not allowed to provide their services to marijuana businesses even in states with legal cannabis programs.
Telsey Advisory Group analyst Dana Telsey reiterated a Market Perform rating on the shares of Peloton Interactive Inc (NASDAQ:PTON) with a price target…